J. Fröhlich

3.2k total citations
79 papers, 2.0k citations indexed

About

J. Fröhlich is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, J. Fröhlich has authored 79 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 25 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Cancer Research. Recurrent topics in J. Fröhlich's work include Lipoproteins and Cardiovascular Health (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers) and Cancer, Lipids, and Metabolism (15 papers). J. Fröhlich is often cited by papers focused on Lipoproteins and Cardiovascular Health (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers) and Cancer, Lipids, and Metabolism (15 papers). J. Fröhlich collaborates with scholars based in Canada, United States and United Kingdom. J. Fröhlich's co-authors include P. Haydn Pritchard, M Dobiášová, Michael R. Hayden, Ingmar Jungner, C.D. Furberg, Anthony Keech, Göran Walldius, John S. Hill, Roger S. McLeod and William Godolphin and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

J. Fröhlich

74 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Fröhlich Canada 25 1.1k 863 471 362 325 79 2.0k
A.F.H. Stalenhoef Netherlands 21 1.2k 1.1× 777 0.9× 590 1.3× 380 1.0× 350 1.1× 44 2.2k
Dov Gavish Israel 26 1.1k 1.0× 787 0.9× 714 1.5× 386 1.1× 371 1.1× 70 2.7k
A.H.M. Smelt Netherlands 23 819 0.7× 764 0.9× 445 0.9× 225 0.6× 277 0.9× 52 1.8k
John W. Gaubatz United States 27 1.5k 1.3× 710 0.8× 450 1.0× 658 1.8× 529 1.6× 42 2.7k
C.J. Packard United Kingdom 21 925 0.8× 999 1.2× 395 0.8× 370 1.0× 369 1.1× 58 2.2k
B Angelin Sweden 22 943 0.8× 576 0.7× 275 0.6× 254 0.7× 407 1.3× 28 1.7k
Jonathan L. Isaacsohn United States 22 1.5k 1.3× 725 0.8× 582 1.2× 289 0.8× 226 0.7× 50 2.4k
Gabriele Bittolo Bon Italy 20 902 0.8× 870 1.0× 451 1.0× 228 0.6× 304 0.9× 43 2.3k
Teik Chye Ooi Canada 27 1.2k 1.0× 1.0k 1.2× 633 1.3× 309 0.9× 361 1.1× 79 2.4k
L. Toivanen Finland 4 1.1k 1.0× 764 0.9× 546 1.2× 178 0.5× 252 0.8× 4 1.9k

Countries citing papers authored by J. Fröhlich

Since Specialization
Citations

This map shows the geographic impact of J. Fröhlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Fröhlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Fröhlich more than expected).

Fields of papers citing papers by J. Fröhlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Fröhlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Fröhlich. The network helps show where J. Fröhlich may publish in the future.

Co-authorship network of co-authors of J. Fröhlich

This figure shows the co-authorship network connecting the top 25 collaborators of J. Fröhlich. A scholar is included among the top collaborators of J. Fröhlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Fröhlich. J. Fröhlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Sarraf, Ahmad, et al.. (2012). Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease: Table 1. BMJ Case Reports. 2012. bcr1220115369–bcr1220115369. 2 indexed citations
2.
Smetana, Jan, J. Fröhlich, Vladimíra Vranová, et al.. (2011). Oligonucleotide-based array CGH as a diagnostic tool in multiple myeloma patients.. PubMed. 24 Suppl. S43–8. 6 indexed citations
3.
Hill, John S., Claire Heslop, S. F. Paul Man, et al.. (2011). Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. European Heart Journal. 32(15). 1918–1925. 50 indexed citations
4.
Al‐Sarraf, Ahmad, John S. Hill, Kristina Sachs‐Barrable, et al.. (2010). Hepatic lipase deficiency in a Middle-Eastern-Arabic male: Table 1. BMJ Case Reports. 2010. bcr1220092589–bcr1220092589. 6 indexed citations
5.
Sujansky, Walter, et al.. (2009). The Development of a Highly Constrained Health Level 7 Implementation Guide to Facilitate Electronic Laboratory Reporting to Ambulatory Electronic Health Record Systems. Journal of the American Medical Informatics Association. 16(3). 285–290. 14 indexed citations
6.
Staples, John A., Paul A. Taylor, Alex B. Magil, et al.. (2008). Progressive kidney disease in three sisters with elevated lipoprotein(a). Nephrology Dialysis Transplantation. 23(5). 1756–1759. 1 indexed citations
7.
Normén, Lena, Benita Yip, Julio Montaner, et al.. (2007). Use of metabolic drugs and fish oil in HIV‐positive patients with metabolic complications and associations with dyslipidaemia and treatment targets. HIV Medicine. 8(6). 346–356. 10 indexed citations
8.
Lynn, Edward G., Yaw L. Siow, J. Fröhlich, Giselle Cheung, & O Karmin. (2001). Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-κB. Kidney International. 60(2). 520–532. 29 indexed citations
9.
Kingsbury, Kori & J. Fröhlich. (2001). The Atherosclerosis Reversal Clinic: The Way of the Future. Advances in experimental medicine and biology. 331–335.
10.
Fröhlich, J., et al.. (1997). 2.P.195 Gender differences in prediction of coronary artery disease (CAD) by plasma lipoproteins, LCAT measurements. Atherosclerosis. 134(1-2). 157–157. 3 indexed citations
11.
Winder, A F, Richard H. Alexander, A Garner, et al.. (1996). The pathology of cornea in Tangier disease (familial high density lipoprotein deficiency).. Journal of Clinical Pathology. 49(5). 407–410. 6 indexed citations
12.
Tonstad, Serena, R. F. Bing, J. Fröhlich, et al.. (1995). Effectiveness of Colestipol Tablets vs Granules in Patients with Moderate to Severe Hypercholesterolaemia. Clinical Drug Investigation. 10(5). 257–263. 3 indexed citations
13.
Civeira, Fernando, J.H.J. van den Berg, Edward Janus, et al.. (1994). Homozygous Tangier disease and cardiovascular disease. Atherosclerosis. 107(1). 85–98. 187 indexed citations
14.
Rader, Daniel J., Katsunori Ikewaki, Nicolas Duverger, et al.. (1994). Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.. Journal of Clinical Investigation. 93(1). 321–330. 98 indexed citations
15.
Fröhlich, J., et al.. (1989). Lipid profile of body builders with and without self-administration of anabolic steroids. European Journal of Applied Physiology. 59(1-2). 98–103. 26 indexed citations
16.
Sparks, Daniel L., J. Fröhlich, Andras G. Lacko, & P. Haydn Pritchard. (1989). Relationship between cholesteryl ester transfer activity and high density lipoprotein composition in hyperlipidemic patients. Atherosclerosis. 77(2-3). 183–191. 28 indexed citations
17.
Fröhlich, J., et al.. (1988). Lipid and lipoprotein changes during the seven days off oral contraception in women using two triphasic preparations. Contraception. 38(1). 19–26. 3 indexed citations
18.
Hayden, Michael R., et al.. (1987). DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias.. PubMed. 40(5). 421–30. 105 indexed citations
19.
20.
Fröhlich, J., et al.. (1978). Familial LCAT Deficiency Report of Two Patients from a Canadian Family of Italian and Swedish Descent. Scandinavian Journal of Clinical and Laboratory Investigation. 38. 156–161. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.F.H. Stalenhoef Breakdown of academic impact, for papers by Dov Gavish Breakdown of academic impact, for papers by A.H.M. Smelt Breakdown of academic impact, for papers by John W. Gaubatz Breakdown of academic impact, for papers by C.J. Packard Breakdown of academic impact, for papers by B Angelin Breakdown of academic impact, for papers by Jonathan L. Isaacsohn Breakdown of academic impact, for papers by Gabriele Bittolo Bon Breakdown of academic impact, for papers by Teik Chye Ooi Breakdown of academic impact, for papers by L. Toivanen
Rankless by CCL
2026